IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?

Abstract   Classification of myeloproliferative neoplasms is based on hematologic, histopathologic and molecular characteristics including the presence of the BCR-ABL1 and JAK2 V617F or MPL and CALR. Although the different gene mutations ought to be mutually exclusive, a number of cases with...

Full description

Bibliographic Details

Published in:	Mediterranean Journal of Hematology and Infectious Diseases
Main Authors:	Federica Sorà, Patrizia Chiusolo, Francesco autore, Sabrina Giammarco, luca laurenti, elisabetta metafuni, idanna innocenti, eugenio galli, andrea bacigalupo, simona sica
Format:	Article
Language:	English
Published:	PAGEPress Publications 2021-10-01
Subjects:	chronic myeloid leukemia myelofibrosis JAK2 allogeneic transplantation
Online Access:	http://mjhid.org/index.php/mjhid/article/view/4702